Healthcare
Bayou Surgical
Recorded May 28, 2026
troCarWash has the potential to shorten operation times, improve outcomes, and reduce costs
troCarWash has the potential to shorten operation times, improve outcomes, and reduce costs
An immuno-corrective approach for the 25 million people with autoimmune diseases who currently don’t respond to treatment
Oban BioPharma is developing a novel oral treatment class for Type 2 diabetes and obesity that works across multiple pathways involved in metabolism at once
Cycurion delivers a fully cloud-native, hardware-free security architecture that detects, mitigates, and neutralizes threats in real time
An immuno-corrective approach for the 25 million people with autoimmune diseases who currently don’t respond to treatment
Oban BioPharma is developing a novel oral treatment class for Type 2 diabetes and obesity that works across multiple pathways involved in metabolism at once
Cycurion delivers a fully cloud-native, hardware-free security architecture that detects, mitigates, and neutralizes threats in real time
MadSci is developing the world’s first SmartShunt, that uses an intercranial fluid sensor to monitor and control a ICF pressure
Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.
Object Pharma is creating a novel, non-systemic neurotoxin platform to help solve today’s mental health crisis
MadSci is developing the world’s first SmartShunt, that uses an intercranial fluid sensor to monitor and control a ICF pressure
Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.